The role of cholecystokinin (CCK8) on glucose production and elimination, and on plasma insulin and glucose in rats.
The effects of the gastrointestinal hormone and neurotransmitter cholecystokinin (CCK8) are complex, since it exhibits both an insulinotropic and a glucagonotropic effect. We investigated CCK8 in vivo with respect to glucose fluxes (production and elimination) at both low (6 mM) and high plasma glucose levels (9 mM) using the primed constant D-[3-3H]glucose infusion technique. In the presence of high glucose levels there was a dose-dependent increase in glucose elimination by CCK8. No effect of CCK8 on glucose production at a high glucose infusion rate (500 mg/kg per h) was observed in contrast to a low glucose infusion rate (100 mg/kg per h); plasma glucagon levels were elevated. All effects on glucose production and elimination were specific, since they were abolished by the CCK receptor antagonist L-364,718. In summary, glucose elimination was slightly increased by CCK8 at low glucose levels but increased to a greater extent at high glucose levels; glucose production was increased by CCK8 only at low glucose levels. Thus, CCK is a regulator of glucose homeostasis.
Verspohl
E J
EJ
Department of Pharmacology, University of Tuebingen, Germany.
Zoll
C
C
Wahl
M A
MA
Ammon
H P
HP
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D001786:Blood Glucose / Q000378:metabolism*; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000502:physiology*; D020109:Devazepide; D005947:Glucose / Q000096:biosynthesis / Q000378:metabolism*; D006706:Homeostasis; D007328:Insulin / Q000097:blood*; D008297:Male; D051381:Rats
D001570:Benzodiazepinones; D001786:Blood Glucose; D007328:Insulin; D002766:Cholecystokinin; D005947:Glucose; D020109:Devazepide